The Beacon ® optofluidic platform maintains ... thus quickening the process of antibody (drug) discovery. The company also offers mouse monoclonal antibody humanization services.

Antibody–drug conjugates have emerged as a powerful tool to deliver highly targeted cancer therapies. Next-generation antibody-drug conjugate designs aim to push the envelope even further.

Highlighted by Genentech's recent US regulatory submission for trastuzumab–DM1, antibody–drug conjugation technology could be heading for the mainstream in anticancer drug development.

biological drug development, and other applications. Sino Biological offers a variety of fast antibody production services, including fast mouse monoclonal antibody production, fast rabbit polyclonal ...

Jasper Therapeutics will present preliminary data from the BEACON study of briquilimab, which could enhance the visibility and interest in their novel antibody therapy. The inclusion of Dr.

Using a novel approach, early testing shows that targeting the protein with an antibody drug conjugate (ADC) could hold promise in improving treatment. The research, which was funded by the blood ...